LAB vs TM · rev $174.4M vs P/E 9.7, rev $234.60B
Standard Biotools Inc (LAB) versus Toyota Motor Corporation ADR (TM) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Toyota Motor Corporation ADR (TM) is a auto manufacturers company listed on NYSE.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported TM revenue for 2013-03-31 was $234.60B. Net income was $10.23B. Revenue was up 3.8% from 2012-03-31 to 2013-03-31. TM currently screens at market cap $211.00B and trailing P/E 9.7.
LAB currently screens at market cap $317.1M. TM currently screens at market cap $211.00B and trailing P/E 9.7.
Not investment advice. Open the LAB and TM stock pages for the full models.
Not investment advice.